BIO-PREDISC-TIA SWISS Cohort Study

Dr. med. Carlo Cereda

Status: Completed

Conditions: Cerebrovascular Disease, Ischemic Stroke

Study type: Observational

Funder types: Other

Identifiers

NCT03994003

EOC.NSISU.4.12.99

Details and patient eligibility

About

This research project aims at contributing to improve TIA diagnosis and management by using PREDISC scores and specific biomarkers thought to have elevated levels in TIA patients. A swift and accurate TIA diagnosis allows starting treatment of the patient adequately and shortly after the event. The shorter the time between the event and treatment onset, the better the outcome. This approach will be an important step forward in TIA diagnosis and management, similarly to acute coronary syndrome as discussed above.

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with suspected TIA (defined as the acute onset of focal neurological symptoms lasting <24 h and presumed to be caused by brain ischemia at the time of referral) within 48 h of symptoms onset.

  • At least 18 years old.
  • Having given their Informed Consent.

Exclusion criteria

• · Patients with ocular TIA (Amaurosis fugax).

  • Patients that still have neurological deficits at the moment of inclusion.
  • Contraindication to perform MRI.
  • For women: pregnancy.